There's no single way to take an anti-inflammatory. Tablets, capsules, injectable solutions, transdermal patches, gels, ...
Analytics and quantitative approaches are shedding more light on these complex formulations, promising to improve process control and product design. Ointments and creams may be as old as humanity ...
Topical formulations are typically disease-specific, so often certain other properties must be achieved or avoided. For instance, Nalamothu notes that for an acne formulation, oily excipients and ...
As discussed in Chapter 2, there are potential advantages for the use of topical medications to treat pain indications, including provision of local, regional, and systemic therapeutic effects, as ...
Quoin Pharmaceuticals Ltd. has announced the filing of U.S. and International patent applications for new topical formulations of rapamycin aimed at treating rare diseases such as microcystic ...
Vyome receives Chinese patent covering formulation and therapeutic use claims relating to its proprietary besifloxacin topical gel programme for inflammatory acne: Cambridge, Mass ...
Opinions expressed by Digital Journal contributors are their own. Amitkumar Patel has spent his career accelerating innovation adoption. His approach to reimagining patient access through precision ...
ASHBURN, Va., March 04, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on rare and ...
Nobelpharma America has become the first company to win FDA approval for a topical treatment for facial angiofibroma associated with tuberous sclerosis complex (TSC). The approval covers a topical gel ...
Vyome Holdings, Inc. (NASDAQ: HIND) (“Vyome” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies ...
The US Food and Drug Administration (FDA) said Tuesday it has become aware of reports of adverse events associated with compounded topical finasteride products, and it has issued an alert for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results